Comparative Treatment Persistence and Adherence to Endothelin Receptor Antagonists Among Patients with Pulmonary Arterial Hypertension in Japan: A Real-World Administrative Claims Database Study-Reference-Cited by-同舟云学术

Comparative Treatment Persistence and Adherence to Endothelin Receptor Antagonists Among Patients with Pulmonary Arterial Hypertension in Japan: A Real-World Administrative Claims Database Study

Published:2023-11-22 Issue:4 Volume:9 Page:511-526
ISSN:2364-1754
Container-title:Pulmonary Therapy
language:en
Short-container-title:Pulm Ther

Author:

Omura Junichi,Makanji Yogeshwar,Tanabe Nobuhiro,Yu Dae Young,Tan Jin Yu,Lim Sooyeol,Kouhkamari Mahsa H.,Casorso Jeremy,Wu David Bin-Chia,Bloomfield Paul

Funder

Janssen Asia Pacific Medical Affairs

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Respiratory Care

Link

https://link.springer.com/content/pdf/10.1007/s41030-023-00244-w.pdf

Reference40 articles.

1. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351(14):1425–36.

2. Gao XF, Zhang JJ, Jiang XM, et al. Targeted drugs for pulmonary arterial hypertension: a network meta-analysis of 32 randomized clinical trials. Patient Prefer Adherence. 2017;11:871–85.

3. Lin H, Wang M, Yu Y, et al. Efficacy and tolerability of pharmacological interventions for pulmonary arterial hypertension: a network meta-analysis. Pulm Pharmacol Ther. 2018;50:1–10.

4. Wang S, Yu M, Zheng X, Dong S. A Bayesian network meta-analysis on the efficacy and safety of eighteen targeted drugs or drug combinations for pulmonary arterial hypertension. Drug Deliv. 2018;25(1):1898–909.

5. Zhang YJ, Wang N, Gu ZC, et al. A network meta-analysis for safety of endothelin receptor antagonists in pulmonary arterial hypertension. Cardiovasc Diagn Ther. 2019;9(3):239–49.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of pulmonary hypertension in special conditions;European Respiratory Journal;2024-08-29